Antiplatelet therapy with aspirin: from clinical trials to practice.
Goodnight
S H
SH
Oregon Health Sciences University, Portland 97201-3098, USA.
D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D004730:Endothelium, Vascular / Q000378:metabolism; D011464:Epoprostenol / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide / Q000378:metabolism; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013927:Thrombosis / Q000188:drug therapy* / Q000517:prevention & control; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D009569:Nitric Oxide; D014859:Warfarin; D011464:Epoprostenol; D001241:Aspirin